US50180M1080
US50180M1080
LB Pharmaceuticals Inc
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 30.404.000 | 64.830.000 | 53.1% | |
| Operating Income | -30.404.000 | -64.830.000 | 53.1% |
| Pretax Income | -25.204.000 | -63.101.000 | 60.1% |
| Net Income Common Stockholders | -25.205.000 | -63.102.000 | 60.1% |
| -- | -- | -- | |
| -- | -- | -- |